Literature DB >> 15102022

Procoagulant surface exposure and apoptosis in rabbit platelets: association with shortened survival and steady-state senescence.

M L Rand1, H Wang, K W A Bang, K S V Poon, M A Packham, J Freedman.   

Abstract

BACKGROUND: The signal(s) for removal of senescent platelets from the circulation are not fully understood; phosphatidylserine (PS) expression on platelets and another marker of apoptosis, loss of mitochondrial inner membrane potential (DeltaPsim), have been implicated in platelet clearance.
OBJECTIVE: To investigate whether shortened platelet survival and steady-state platelet senescence are associated with increased surface exposure of PS and DeltaPsim collapse.
METHODS: Survival of in-vitro biotinylated rabbit platelets treated with thrombin or Ca(2+)-ionophore A23187 was tracked by flow cytometry after injection. Steady-state platelet senescence was investigated by infusing biotin to label a platelet cohort. PS expression and DeltaPsim of in-vitro biotinylated platelets and of the aging platelet cohort biotinylated in-vivo were measured by flow cytometry using annexin V-FLUOS and the DeltaPsim-sensitive dye CMXRos, respectively.
RESULTS: Although PS expression, DeltaPsim and survival of thrombin-degranulated platelets were similar to those of control platelets, increasing concentrations of A23187 caused increased surface exposure of PS and progressive shortening of platelet survival; only one-sixth of PS-expressing platelets also exhibited DeltaPsim loss. The cohort of senescent, biotinylated platelets remaining in the circulation at 96 h had increased exposure of PS and collapsed DeltaPsim; of the 17% of PS-expressing platelets, one-third did not exhibit DeltaPsim loss. There was also an increase in platelets with collapsed DeltaPsim but not expressing PS.
CONCLUSIONS: Platelets with shortened survival and senescent platelets have increased surface exposure of PS, that may be involved in their clearance. PS expression can occur independently of DeltaPsim collapse and conversely, in aged platelets, DeltaPsim loss can occur independently of PS expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102022     DOI: 10.1111/j.1538-7836.2004.00670.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  11 in total

1.  Platelet senescence and phosphatidylserine exposure.

Authors:  Swapan Kumar Dasgupta; Eduardo Rios Argaiz; Jose Emmanel Chedid Mercado; Hector Omar Elizondo Maul; Jorge Garza; Ana Bety Enriquez; Hanan Abdel-Monem; Anthony Prakasam; Michael Andreeff; Perumal Thiagarajan
Journal:  Transfusion       Date:  2010-10-04       Impact factor: 3.157

Review 2.  Markers of platelet apoptosis: methodology and applications.

Authors:  Armen V Gyulkhandanyan; Asuman Mutlu; John Freedman; Valery Leytin
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

3.  Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia.

Authors:  Mattias Olsson; Pierre Bruhns; William A Frazier; Jeffrey V Ravetch; Per-Arne Oldenborg
Journal:  Blood       Date:  2005-01-21       Impact factor: 22.113

4.  Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis.

Authors:  Shawn M Jobe; Katina M Wilson; Lorie Leo; Alejandro Raimondi; Jeffery D Molkentin; Steven R Lentz; Jorge Di Paola
Journal:  Blood       Date:  2007-11-07       Impact factor: 22.113

5.  Platelet hyperreactivity explains the bleeding abnormality and macrothrombocytopenia in a murine model of sitosterolemia.

Authors:  Taisuke Kanaji; Sachiko Kanaji; Robert R Montgomery; Shailendra B Patel; Peter J Newman
Journal:  Blood       Date:  2013-08-07       Impact factor: 22.113

6.  Alzheimer disease and platelets: how's that relevant.

Authors:  Silvia Catricala; Mauro Torti; Giovanni Ricevuti
Journal:  Immun Ageing       Date:  2012-09-17       Impact factor: 6.400

7.  Platelet dysfunction in injured patients.

Authors:  Noelle N Saillant; Carrie A Sims
Journal:  Mol Cell Ther       Date:  2014-12-19

8.  Platelets in hemostasis and thrombosis: Novel mechanisms of fibrinogen-independent platelet aggregation and fibronectin-mediated protein wave of hemostasis.

Authors:  Yan Hou; Naadiya Carrim; Yiming Wang; Reid C Gallant; Alexandra Marshall; Heyu Ni
Journal:  J Biomed Res       Date:  2015-10-30

9.  Dual role of the p38 MAPK/cPLA2 pathway in the regulation of platelet apoptosis induced by ABT-737 and strong platelet agonists.

Authors:  N Rukoyatkina; I Mindukshev; U Walter; S Gambaryan
Journal:  Cell Death Dis       Date:  2013-11-21       Impact factor: 8.469

10.  A study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products: the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial.

Authors:  Paula F Ypma; Pieter F van der Meer; Nancy M Heddle; Joost A van Hilten; Theo Stijnen; Rutger A Middelburg; Tor Hervig; Johanna G van der Bom; Anneke Brand; Jean-Louis H Kerkhoffs
Journal:  BMJ Open       Date:  2016-01-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.